Amelia joined the team as the UCL Study Coordinator for GENFI in June 2024. She completed her BSc in Psychology at the University of Reading and an MSc in Clinical Neurodevelopmental Sciences at King’s College London. In October 2025, Amelia began her PhD, focusing on the development of novel digital biomarkers for frontotemporal dementia (FTD).
- FTD UK (Edinburgh, May 2025): Early changes in heart rate variability in asymptomatic FTD mutation carriers.
- ISFTD (Amsterdam, September 2024): The Ignite app detects early cognitive impairments and correlates with disease severity in genetic FTD
